Seronegative Lambert-Eaton myasthenic syndrome: Study of 110 japanese patients

Neurology

Volumn 59, Issue 11, 2002, Pages 1773-1775

  Nakao, Y K ^a   Motomura, M ^a   Fukudome, T ^b   Fukuda, T ^a   Shiraishi, H ^a   Yoshimura, T ^c   Tsujihata, M ^d   Eguchi, Katsumi ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Nagasaki Kawatana Medical Center   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

^d Nagasaki Kita Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VOLTAGE GATED CHANNEL FORMING PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EATON LAMBERT SYNDROME; FEMALE; HUMAN; IMMUNOLOGY; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PASSIVE TRANSPORT; PRIORITY JOURNAL; SERODIAGNOSIS;

EID: 0037058751     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000037485.56217.5F     Document Type: Article

References (10)

1. Lang B, Newsom-Davis J, Prior C, Wray D. Antibodies to motor nerve terminals: An electrophysiological study of a human myasthenic syndrome transferred to mouse. J Physiol 1983;344:335-345.
2. O'Neill JH, Murray NM, Newsom-Davis J. The Lambert-Eaton myasthenic syndrome: A review of 50 cases. Brain 1988; 111:577-596.
3. Protii DA, Reisin R, Mackinley TA, Uchitel OD. Calcium channel blockers and transmitter release at the normal human neuromuscular junction. Neurology 1996;46:1391-1396.
4. Motomura M, Johnston I, Lang B, Vincent A, Newsom-Davis J. An improved diagnostic assay for Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry 1995;58:85-87.
5. Nakao YK, Motomura M, Suenaga A, et al. Specificity of ω-conotoxin MVIIC binding and blocking calcium channel antibodies in Lambert-Eaton myasthenic syndrome. J Neurol 1999;246:38-44.
6. Gutmann L, Phillips LH II, Gutmann L. Trends in the association of Lambert-Eaton myasthenic syndrome with carcinoma. Neurology 1992;42:848-850.
7. Soliven BC, Lange DJ, Penn AS. Seronegative myasthenia gravis. Neurology 1988;38:514-517.
8. Verma PK, Oger JJ. Seronegative generalized myasthenia gravis: Low frequency of thymic pathology. Neurology 1992;42:586-589.
9. Burges J, Vincent A, Molenaar PC, et al. Passive transfer of seronegative myasthenia gravis to mice. Muscle Nerve 1994; 17:1393-1400.
10. Hoch W, McConville J, Helms S, et al. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 2001;7:365-368.